...
首页> 外文期刊>Egyptian Journal of Anaesthesia >Preincisional peritonsillar vs. intravenous lornoxicam for posttonsillectomy analgesia: A clinical and platelet aggregometry comparative study
【24h】

Preincisional peritonsillar vs. intravenous lornoxicam for posttonsillectomy analgesia: A clinical and platelet aggregometry comparative study

机译:切口前扁桃体与静脉注射氯诺昔康用于扁桃体切除术后镇痛的临床和血小板凝集比较研究

获取原文
           

摘要

Background Lornoxicam is a fairly new short-half oxicam with an improved tolerability profile. Our objective was to investigate the safety and efficacy of intravenous and peritonsillar infiltration of 8 mg lornoxicam on pain relief in children undergoing tonsillectomy. Methods In a double-blinded, placebo-controlled trial, 60 children were randomized into three groups; intravenous group ( n = 20), received lornoxicam 8 mg iv., infiltration group ( n = 20) received lornoxicam 8 mg peritonsillar infiltration, and placebo controls ( n = 20). The verbal rating pain scale, time to first postoperative analgesic request, total analgesic consumption during 1st 24 h postoperative, platelet aggregometry before, 15 min, 2 and 24 h after study drug administration, intraoperative blood loss, postoperative bleeding, and adverse effects were evaluated. Results The time to first postoperative analgesic request was significantly prolonged in intravenous (318.75 ± 67.37 min) and infiltration (214.50 ± 43.06 min) groups compared with placebo group (66.75 ± 26.95 min). A significantly lower mean postoperative VRS scores and significantly reduced 1st day postoperative diclofenac consumption were recorded in iv. group (44.73 ± 9.31 mg), compared with infiltration (69.80 ± 38.71 mg) and placebo (87.8 ± 24.40 mg) groups. An increased intraoperative blood volume losses and intraoperative bleeding complains were observed in infiltration group (34.25 ± 11.93 ml), rather than in iv. (28.85 ± 10.01 ml) and placebo (24.75 ± 8.70 ml) groups. The (%) of platelet aggregation with ADP, collagen, and arachidonic acid was significantly reduced 15 min and 2 h after study drug administration with highest decreases in iv. group compared with infiltration and placebo groups. No patients reported postoperative bleeding or GIT adverse effects in the study. Conclusion Intraoperative preincisional intravenous lornoxicam enhanced postoperative analgesia after tonsillectomy in children. In comparison, the analgesic efficacy of locally applied lornoxicam was inferior to intravenous administration and was associated with increased incidence of intraoperative bleeding.
机译:背景氯诺昔康是一种相当新的具有增强的耐受性特征的短二恶英。我们的目的是研究8mg氯诺昔康静脉和扁桃体浸润对扁桃体切除术患儿缓解疼痛的安全性和有效性。方法在一项双盲,安慰剂对照试验中,将60名儿童随机分为三组。静脉注射组(n = 20),接受氯诺昔康8 mg iv。浸润组(n = 20),接受氯诺昔康8 mg扁桃体浸润,和安慰剂对照(n = 20)。评估语言评分疼痛量表,首次术后镇痛的时间,术后1-24小时的总镇痛消耗量,研究药物给药前,15分钟,2和24小时后的血小板凝集度,术中失血量,术后出血量和不良反应。结果与安慰剂组(66.75±26.95 min)相比,静脉(318.75±67.37 min)和浸润(214.50±43.06 min)组的首次术后止痛时间明显延长。静脉内记录到术后平均VRS评分明显降低,术后第一天服用双氯芬酸明显减少。对照组(44.73±9.31 mg),而浸润组(69.80±38.71 mg)和安慰剂组(87.8±24.40 mg)比较。浸润组(34.25±11.93 ml)而非静脉注射组观察到术中血容量损失增加和术中出血症状增加。 (28.85±10.01 ml)和安慰剂(24.75±8.70 ml)组。服用研究药物后15分钟和2小时,与ADP,胶原蛋白和花生四烯酸的血小板凝集(%)显着降低,静脉内降幅最大。组与浸润组和安慰剂组相比。在该研究中,没有患者报告术后出血或GIT不良反应。结论术中术前静脉注射氯诺昔康可增强小儿扁桃体切除术后的镇痛效果。相比之下,局部应用氯诺昔康的镇痛效果不如静脉内给药,并且与术中出血的发生率增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号